Drug Profile
Research programme: HIV vaccine - Pecan Biotherapeutics
Alternative Names: Tat Oyi vaccine - Pecan Biotherapeutics; Tat Oyi-Cys22 vaccine - Pecan Biotherapeutics; Therapeutic HIV vaccine - Pecan Biotherapeutics; Third-generation HIV vaccine (Tat Oyi-Cys22) - Pecan BiotherapeuticsLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pecan Biotherapeutics
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in HIV-infections in USA
- 25 Feb 2010 Preclinical development is ongoing in USA